![Neil Klompas](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Neil Klompas
Directeur/Membre du Conseil chez
NERVGEN PHARMA CORP.
Fortune : - $ au 30/06/2026
Profil
Neil A. Klompas is President & Chief Executive Officer at Augurex Life Sciences Corp.
since 2024.
Mr. Klompas is Director at HTuO Biosciences, Inc., Canadian Gene Cure Foundation, and The Chartered Professional Accountants of British Columbia.
Mr. Klompas is Independent Non-Executive Director at NervGen Pharma Corp.
since 2024.
Mr. Klompas is Director at InMed Pharmaceuticals, Inc. starting 2025.
Formerly, Mr. Klompas was Chairman at Ovensa, Inc. and Independent Director at Liminal BioSciences, Inc. Mr. Klompas was Chief Operating Officer at Zymeworks BC, Inc. in 2022.
Mr. Klompas was Manager-Mergers & Acquisitions Transactions at KPMG LLP from 2005 to 2007.
Mr. Klompas was Audit Manager at KPMG LLP (Canada) from 2000 to 2005.
Mr. Klompas was President & Chief Operating Officer at Zymeworks, Inc. from 2022 to 2023.
Mr. Klompas completed undergraduate studies at the University of British Columbia.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NERVGEN PHARMA CORP. -.--% | 16/05/2025 | 0 ( -.--% ) | - $ | 30/06/2026 |
| 19/12/2025 | 0 ( -.--% ) | - $ | 30/06/2026 |
Postes actifs de Neil Klompas
| Sociétés | Poste | Début |
|---|---|---|
| NERVGEN PHARMA CORP. | Directeur/Membre du Conseil | 22/07/2024 |
| INMED PHARMACEUTICALS INC. | Directeur/Membre du Conseil | 09/10/2025 |
The Chartered Professional Accountants of British Columbia
 The Chartered Professional Accountants of British Columbia Miscellaneous Commercial ServicesCommercial Services Operates as an association of accountants | Corporate Officer/Principal | - |
Canadian Gene Cure Foundation
 Canadian Gene Cure Foundation The Canadian Gene Cure Foundation is a company based in Victoria, Canada. | Directeur/Membre du Conseil | - |
Augurex Life Sciences Corp.
 Augurex Life Sciences Corp. Medical SpecialtiesHealth Technology Develops biomarkers that transform patient clinical management | Directeur Général | 06/08/2024 |
HTuO Biosciences, Inc.
 HTuO Biosciences, Inc. BiotechnologyHealth Technology Operates as a bioscience company | Directeur/Membre du Conseil | - |
Anciens postes connus de Neil Klompas
| Sociétés | Poste | Fin |
|---|---|---|
| ZYMEWORKS INC. | President | 30/06/2023 |
Zymeworks BC, Inc.
 Zymeworks BC, Inc. BiotechnologyHealth Technology Develops protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases | Directeur Financier/CFO | 24/02/2022 |
KPMG LLP
 KPMG LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax and advisory services | Corporate Officer/Principal | 01/01/2007 |
| ░░░░ ░░░ ░░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Neil Klompas
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
71
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Liminal BioSciences, Inc.
 Liminal BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops distinctive novel small molecule therapeutics for metabolic, fibrotic and inflammatory diseases | Health Technology |
InMed Pharmaceuticals, Inc.
 InMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures prescription-based products for dermatology and ocular diseases | Health Technology |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Develops protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases | Health Technology |
KPMG LLP
KPMG LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax and advisory services | Commercial Services |
University of British Columbia
 University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
KPMG LLP (Canada)
 KPMG LLP (Canada) Miscellaneous Commercial ServicesCommercial Services Provides audit, tax and advisory services | Commercial Services |
Augurex Life Sciences Corp.
Augurex Life Sciences Corp. Medical SpecialtiesHealth Technology Develops biomarkers that transform patient clinical management | Health Technology |
The Chartered Professional Accountants of British Columbia
The Chartered Professional Accountants of British Columbia Miscellaneous Commercial ServicesCommercial Services Operates as an association of accountants | Commercial Services |
Ovensa, Inc.
 Ovensa, Inc. Internet Software/ServicesTechnology Services Provides nano medicine delivery technology platforms to solve pharmacokinetic challenges | Technology Services |
Canadian Gene Cure Foundation
Canadian Gene Cure Foundation The Canadian Gene Cure Foundation is a company based in Victoria, Canada. | |
NervGen Pharma Corp.
 NervGen Pharma Corp. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops neuroreparative therapeutics and pharmaceutical products for neurological disorders | Health Technology |
HTuO Biosciences, Inc.
HTuO Biosciences, Inc. BiotechnologyHealth Technology Operates as a bioscience company | Health Technology |
Zymeworks, Inc.
 Zymeworks, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Choisissez Zonebourse 
